Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Arista Networks enters the post-earnings stretch with a sharp lift from analysts and an equally sharp sell from its CEO — a split signal that frames the week neatly. The most active story is on the Street. Five…
Moelis & Company heads into this week with a curious split: the stock fell nearly 9% on the week to $63.49, while short sellers were actually trimming rather than pressing. That divergence — selling pressure without a…
TSLX heads into the week after its Q1 2026 report with the borrow market fully tapped out, an elevated short score near 79, and a stock that rallied 3% on the week despite slipping into earnings — a tight, contested…
Ultragenyx Pharmaceutical heads into the post-earnings week with short sellers adding positions and analysts pulling in opposite directions — a split that reflects the market's unresolved read on whether the Q1 revenue…
PRGO reported Q1 2026 results today at the most consequential moment in its multi-year restructuring, landing an earnings beat that markets have greeted cautiously — and for good reason. Adjusted EPS came in at $0.43,…
AMC Entertainment just delivered a Q1 revenue beat — domestic box office jumped 22% — yet the lending market for its stock has simultaneously reached maximum tightness, creating an unusually charged backdrop as short…
ABEV3 erupted higher on May 5, gaining 15.3% in a single session after reporting Q1 2026 results — its biggest one-day move in recent memory — and the question now is whether the rally has left positioning and…
Veracyte enters the post-earnings stretch with short sellers sitting on a meaningful but stabilising position — a setup where the headline numbers are less interesting than the direction of travel. Short interest has…
CRTO reported Q1 2026 results this morning, delivering an earnings beat that failed to lift the stock above its recent range — and the tension between a clean headline print and a guarded revenue outlook defines the…
Fate Therapeutics enters its May 14 earnings call riding an extraordinary week — the stock doubled on a regulatory catalyst while short sellers quietly trimmed positions and call buyers dominated the options…
CDW enters the post-earnings stretch carrying two contradictory signals: revenue that surprised to the upside and a short book that has grown 22% in a month. Q1 results, reported this morning, set the tone for the…
VOYA has staged a sharp recovery — up 24% over the past month to $83.11 — and short sellers have been moving the other way just as fast. Short interest in Voya Financial has collapsed from a near-term peak, shedding…
GlucoTrack, Inc. heads into the week with one of the most extreme short-interest profiles in the small-cap health care universe — a stock priced at $0.73 and falling, with bears commanding a position that dwarfs the…
Bright Horizons Family Solutions enters June earnings prep in an unusual position: the Street's biggest bulls are cutting price targets even as the company holds its ground, leaving a widening gap between analyst…
Travere Therapeutics arrives at the close of this week carrying two competing stories: a Q1 earnings beat that pulled the entire sell-side to raise its targets, and a cluster of insider sales from the same management…
Wheeler Real Estate Investment Trust enters its May 8 earnings release under intense short pressure — short interest has nearly tripled in a month, cost to borrow is running at 340%, and a majority shareholder has been…
MPLX reported Q1 earnings on May 5 and delivered the kind of quiet beat that defines its investment case — a 1.7% one-day gain and a further drift higher through the week. The stock closed Wednesday at $55.66, up about…
Hyster-Yale delivered a rare positive surprise this week — one that the market treated as a turning point rather than a consolation prize. The forklift maker posted Q1 2026 adjusted EPS of -$1.64, clearing the -$1.80…
Par Pacific Holdings enters the week of May 6 in an unusual spot: the stock has finally caught up to where Goldman Sachs thought it should be, while insiders had already been quietly heading for the exits. The week's…
QLYS just printed a beat-and-raise quarter — yet analysts are cutting targets, short sellers have rebuilt a 13% position, and the stock is still trading 30% below where it started the year. The numbers on Tuesday…
